articleJournal of the American Academy of DermatologyJun 17, 2015BRONZE OA

Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate to severe plaque psoriasis: CLEAR, a randomized controlled trial

DTDiamant ThaçiABAndrew BlauveltKRKristian ReichTTTsen‐Fang TsaiFVF. Vanaclocha

University Hospital Schleswig-Holstein · University of Lübeck · +10 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

540
total citations
FWCI
30.56
Percentile
100%
References
25
Citations per year

Authors

11

Topics & keywords

Topics
Keywords
  • Secukinumab
  • Ustekinumab
  • Medicine
  • Psoriasis Area and Severity Index
  • Dermatology Life Quality Index
  • Psoriasis
  • Placebo
  • Randomized controlled trial
No related works found for this paper.

Funding